ArsenalBio (Series A)

Funding Details

Awarder: Inbox
Date Award: October 17, 2019
Vertical: Biotechnology
Funding URL: View Funding Page
Funding Amount:: $85,000,000

Company Info

Founding Year: 2019
Company Description: ArsenalBio is a programmable cell therapy company that offers CAR T-cell therapies for solid tumors.
Market: Cancer Immunotherapy
Location: South San Francisco, California, USA
Coinvestors: Euclidean Capital, Kleiner Perkins Caufield and Byers, Osage Venture Partners, Parker Institute for Cancer Immunotherapy, UCSF Foundation Investment Company, Westlake Village BioPartners

Links

Back to Home Back to Biotechnology Deals View Funding Announcement